Home > Search Results

Results: 14

Non-Small Cell Lung Cancer Treatment (PDQ®): Health Professional Version

Expert-reviewed information summary about the treatment of non-small cell lung cancer.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: August 6, 2014

Referral Guidelines for Suspected Cancer in Adults and Children [Internet]

The guideline is divided into sections which cover in detail specific topics relating to twelve groups of cancers: lung, upper gastrointestinal cancers, lower gastrointestinal cancers, breast cancer, gynaecological cancers, urological cancers, haematological cancers, skin cancers, head and neck including oral cancers, brain/central nervous system cancers, bone and sarcoma, and children’s and young people’s cancers.

NICE Clinical Guidelines - Clinical Governance Research and Development Unit (CGRDU), Department of Health Sciences, University of Leicester.

Version: June 2005
Show search results within this document

Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®): Health Professional Version

Expert-reviewed information summary about the treatment of childhood central nervous system germ cell tumors.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: April 9, 2015

Langerhans Cell Histiocytosis Treatment (PDQ®): Health Professional Version

Expert-reviewed information summary about the treatment of childhood Langerhans Cell Histiocytosis.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: January 30, 2015

Thyroid Cancer Treatment (PDQ®): Health Professional Version

Expert-reviewed information summary about the treatment of thyroid cancer.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: May 13, 2015

Unusual Cancers of Childhood Treatment (PDQ®): Health Professional Version

Expert-reviewed information summary about the treatment of unusual cancers of childhood such as cancers of the head and neck, chest, abdomen, reproductive system, skin, and others.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: April 6, 2015

Unusual Cancers of Childhood Treatment (PDQ®): Patient Version

Expert-reviewed information summary about the treatment of unusual cancers of childhood such as cancers of the head and neck, chest, abdomen, reproductive system, skin, and others.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: April 10, 2015

Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care [Internet]

This guideline offers best practice advice on the identification and care of patients with chronic obstructive pulmonary disease (COPD). It aims to define the symptoms, signs and investigations required to establish a diagnosis of COPD. It also aims to define the factors that are necessary to assess its severity, provide prognostic information and guide best management. It gives guidance on the pharmacological and non-pharmacological treatment of patients with stable COPD, and on the management of exacerbations. The interface with surgery and intensive therapy units (ITU) are also discussed.

NICE Clinical Guidelines - National Clinical Guideline Centre (UK).

Version: June 2010

Childhood Soft Tissue Sarcoma Treatment (PDQ®): Health Professional Version

Expert-reviewed information summary about the treatment of childhood soft tissue sarcomas.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: January 29, 2015

Adult Brain Tumors Treatment (PDQ®): Health Professional Version

Expert-reviewed information summary about the treatment of adult brain tumors.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: February 25, 2015

Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care [Internet]

This report evaluates the level of evidence currently available to support the effectiveness and safety of using recombinant activated coagulation factor VII (rFVIIa) for clinical indications not approved by the U. S. Food and Drug Administration (FDA). rFVIIa is approved for a variety of uses in hemophilia patients who have developed antibody inhibitors that compromise the use of standard factor replacement. Use of this costly biologic product has expanded beyond these hemophilia-related indications to encompass a range of off-label uses, most of which are in-hospital uses. These uses differ substantially from the drug’s FDA approved label. The purpose of this report is two-fold: (1) To document the full range of clinical indications for which rFVIIa is being used and the types of studies available to evaluate these uses and (2) To provide a comparative effectiveness review of rFVIIa vs. usual care for several in-hospital clinical indications: intracranial hemorrhage, massive bleeding secondary to trauma, and the selected surgical procedures of cardiac surgery, liver transplantation, and prostatectomy.

Comparative Effectiveness Reviews - Agency for Healthcare Research and Quality (US).

Version: May 2010
Show search results within this document

Adult Soft Tissue Sarcoma Treatment (PDQ®): Health Professional Version

Expert-reviewed information summary about the treatment of adult soft tissue sarcoma.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: January 9, 2015

Comparative Effectiveness Review Methods: Clinical Heterogeneity [Internet]

The Agency for Healthcare Research and Quality (AHRQ) funded the RTI International—University of North Carolina at Chapel Hill Evidence-based Practice Center to determine best practices for addressing clinical heterogeneity in systematic reviews (SRs) and comparative effectiveness reviews (CERs). These best practices address critiques from patients, clinicians, policymakers, and others who assert that SRs typically focus on broad populations and, as a result, often lack information relevant to individual patients or patient subgroups.

Methods Research Reports - Agency for Healthcare Research and Quality (US).

Version: September 2010
Show search results within this document

Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control

This is the full version of NICE clinical guideline 117. It contains details of the methods and evidence used to develop the guideline. It updates and replaces the full version of ‘Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control’ that was developed by the National Collaborating Centre for Chronic Conditions and published by the Royal College of Physicians in March 2006. The updated recommendations have been developed by the Centre for Clinical Practice at NICE following the NICE short clinical guideline process. New recommendations on the use of interferon-gamma tests for the diagnosis of latent tuberculosis have been added.

NICE Clinical Guidelines - National Institute for Health and Clinical Excellence (UK).

Version: March 2011
Show search results within this document

Systematic Reviews in PubMed

See all (2)...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...